FDA Approves Three Drugs for Nonprescription Use through Rx-to-OTC Switch Process |
Clinical News
eMediNexus Coverage from: 
FDA Approves Three Drugs for Nonprescription Use through Rx-to-OTC Switch Process

1 Read Comments                

The U.S. Food and Drug Administration has approved three drugs for nonprescription, or over-the-counter (OTC), use through the process of prescription (Rx)-to-OTC switch. The FDA approved Voltaren Arthritis Pain (diclofenac sodium topical gel, 1%) for temporary relief of arthritis pain; Pataday Twice Daily Relief (olopatadine HCl ophthalmic solution/drops, 0.1%) for temporary relief of itchy and red eyes due to pollen, ragweed, grass, animal hair or dander; and Pataday Once Daily Relief (olopatadine HCl ophthalmic solution/drops, 0.2%) for temporary relief of itchy eyes due to pollen, ragweed, grass, animal hair or dander, for nonprescription use… (FDA, February 14, 2020)

To comment on this article,
create a free account.
Sign Up to instantly read 30000+ free Articles & 1000+ Case Studies
Create Account

Already registered?

Login Now